Connect with us

Health

Study Identifies Cytokine Target for Treatment-Resistant Hemophilia A – MD Magazine

Elevated B cell activating factor levels in children and adults were associated with the development of FVIII inhibitors, which may lead to FVIII infusion failures….

Published

on

Article feature image

Findings from a new study shed light on the mechanisms behind patient unresponsiveness to coagulation protein therapy for hemophilia A.
More specifically, investigators note a key target that may lead to treatment failure in up to 30% of patients.
Currently, hemophilia is the most common inherited bleeding disorder, which affects 1 in 10,000 men across the globe. Since patients lack coagulation factor VIII (FVIII), therapies are typically aimed at infusions to replace the missing protein.
Some patients,…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Benefits of drug research are not being shared equitably among study participants, indicates study – News-Medical.Net
Article feature image
Driving Behavior Can Be Used To Detect Signs Of Dementia: Study – Gizmodo Australia